ZincFive Expands Global Reach with Strategic EMEA Warehouse and Service Hub
22.5.2025 15:35:00 EEST | Business Wire | Press release
ZincFive®, the world leader in nickel-zinc (NiZn) battery-based solutions for immediate power applications, today announced a major milestone in its global growth strategy with the establishment of a new warehouse and service depot in Europe. The facility, operated in collaboration with Akkuteam Energietechnik GmbH, will support fast, efficient delivery of ZincFive batteries and spare parts across the EMEA region and beyond.
This certified customs warehouse enables seamless transit of batteries and components through Europe, streamlining exports to non-EU countries such as those in the Middle East. It also advances ZincFive’s sustainability goals by reducing shipping-related emissions and improving logistics efficiency.
The move comes in response to accelerating international demand for ZincFive’s nickel-zinc technology. With many European installations still relying on legacy lead-acid systems, there is a growing appetite for safer, more sustainable, and high-performance alternatives – making ZincFive’s technology uniquely suited to meet modern backup power needs.
“This is more than a logistical move – it’s a signal of our long-term commitment to the EMEA market,” said ZincFive CEO Tim Hysell. “Our values of innovation, sustainability, and reliability are mirrored in this new partnership. With a facility designed for efficient, environmentally responsible battery logistics, we’re not just expanding our footprint – we’re doing it the right way. We’re investing where demand is real and growing – this isn’t speculative; it’s a response to the strong pull we’re seeing from European and Middle Eastern markets.”
Akkuteam brings deep expertise in battery storage and handling and operates with a strong focus on quality and environmental stewardship. As a family-run company with a 25-year history of innovation in backup power solutions, Akkuteam’s commitment to service and future-ready infrastructure closely aligns with ZincFive’s mission to power a greener future through The Power of Good Chemistry®.
ZincFive is uniquely positioned for global growth as power demands rise across sectors – especially in data centers, including the fast-emerging AI segment. Its patented nickel-zinc chemistry – proven in the field for over a decade – delivers safe, sustainable, and high-performance energy storage that challenges the dominance of lead-acid and lithium-ion batteries. The ZincFive BC Series UPS Battery Cabinets – including the latest BC 2–500 and BC 2–300X models – offer an industry-leading footprint while delivering greater power to meet the escalating demands of modern infrastructure. Powered by the new Z5 13-90 ultra-high-rate battery, these solutions continue to raise the bar for compact design, reliability, and sustainability in mission-critical environments.
ZincFive has earned global recognition, including TIME’s 2025 World’s and America’s Top GreenTech Companies lists, the 2024 Edison Award™, CleanTech Breakthrough’s 2024 Overall Innovation of the Year, a finalist spot in the 2023 S&P Platts Global Energy Awards, and several other notable industry honors.
About ZincFive, Inc.
ZincFive is the world leader in innovation and delivery of nickel-zinc batteries and immediate power solutions. Supported by an impressive portfolio of international patents, ZincFive technology harnesses The Power of Good Chemistry® to propel the world forward. ZincFive technology leverages the safety and sustainability of nickel-zinc chemistry to provide unparalleled high power density and performance for mission critical applications. ZincFive is a privately held company based in Tualatin, Oregon. For more information, visit www.zincfive.com.
ZincFive and The Power of Good Chemistry are registered trademarks of ZincFive, Inc. and the ZincFive logo is a trademark of ZincFive, Inc.
Follow ZincFive: LinkedIn | YouTube
View source version on businesswire.com: https://www.businesswire.com/news/home/20250522279972/en/
Contacts
Media Contact:
Ilissa Miller
iMiller Public Relations for ZincFive
Tel: +1.914.315.6424
Email: zincfive@imillerpr.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 16:00:00 EEST | Press release
NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under 20 minutes, saving hundreds of hours of engineer time, shrinking MTTR by more than 95%. A global telecommunications firm found NetBrain's context-grounded agents outperformed a stand-alone frontier LLM on a persistent firewall
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 15:00:00 EEST | Press release
Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consistent approach to protecting our innovation and our customers,” said Justin Ferguson, SVP and general counsel at Adtran. “We take all claims seriously, but we will not hesitate to defend ourselves when assertions lack merit. Situations like this place unnecessary strain on technology providers and divert resources from advancing networks and services. By advancing our counterclaim
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 14:00:00 EEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 13:50:00 EEST | Press release
IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio transformation and is expected to strengthen the company’s focus on its innovation-driven businesses: Taste, Scent, and Health & Biosciences. Following the transaction, IFF will be
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 13:00:00 EEST | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 patients, underscoring consistent effectiveness and safety in clinical practice. Additionally, BEQALZI™ (sonrotoclax), which was recently approved by the U.S. Food and Drug Administration, and its development in combination with BRUKINSA (ZS) highlight the potential for next-generation, time-limited treatment approaches in CLL. Amit Agarwal, M.D., Ph.D., Chief Medical Officer, Hematology, BeOne Medicines, said: “CLL is a disease patients live with
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom